Praj Industries (PRAJIND) Q2 2026 earnings summary

Executive summary

• Q2 and H1 FY26 results reflect strong execution despite headwinds in domestic ethanol and international markets due to U.S. tariffs, with Board and auditor review confirming no material misstatements.

• Domestic ethanol market faces slowdown in greenfield projects; focus shifts to lifecycle services and brownfield enhancements.

• International bioenergy pipeline remains healthy, with the first U.S. low-carbon ethanol project set for commissioning by fiscal year-end.

• Positive policy developments in Latin America and Asia for blending mandates; CBG and SAF segments show early traction.

• Strategic pivot in GenX engineering business towards conventional industries due to delays in energy transition projects.

Financial highlights

• Q2 FY26 consolidated income from operations: INR 8,416.34 million, up from INR 8,161.92 million in Q2 FY25; standalone revenue: INR 6,858.60 million.

• Q2 FY26 consolidated net profit: INR 192.83 million (vs. INR 538.31 million in Q2 FY25); standalone net profit: INR 416.63 million.

• H1 FY26 consolidated income from operations: INR 14,818 million (down 2.2% YoY); net profit: INR 246 million (down 82.2% YoY).

• Q2 FY26 consolidated EBITDA margin dropped 392 bps YoY to 6.64%; PAT margin fell 430 bps to 2.29%.

• Order backlog as of September 30, 2025: INR 44,190 million; cash in hand: INR 4,370 million.

Outlook and guidance

• Recovery expected to be slow; strategic diversification across industrial effluent, pharma, ultra-pure water, and brewery segments to support growth.

• No formal revenue or EBITDA margin guidance provided as per company policy.

• Full capacity utilization at GenX facility now expected by FY28, delayed by a year.

• Industry awaits further policy directives after India achieves EBP 20; funding and site delays continue to impact project execution.

• Positive policy developments expected in international markets, with new opportunities in SAF, CBG, and bioplastics.